Skip to main content
. 2016 May 11;4(1):103–116. doi: 10.1007/s40487-016-0020-4

Table 3.

Logistic regression: factors associated with a treatment decision for capecitabine

Variable Capecitabine (n = 48) 5-FU (n = 109) Odds ratioa 95 % confidence interval
Gender
 Female 21 (35%) 39 (65%) Ref.
 Male 27 (28%) 70 (72%) 1.10 0.45 2.69
Age
 Age at treatment commencement (per year) 66.95 62.55 1.02 0.98 1.07
Marital status
 Married 20 (26%) 57 (74%) Ref.
 Widowed, divorced/separated, never married 19 (32%) 40 (68%) 1.67 0.62 4.45
Religious affiliation
 Religious 23 (28%) 59 (72%) Ref.
 Not religious 5 (19%) 21 (81%) 0.42 0.10 1.77
Distance required to travel to hospital (km)
 0–5  25 (33%) 50 (67%) Ref.
 5–10  15 (30%) 35 (70%) 0.74 0.27 2.02
 10–40  6 (32%) 13 (68%) 1.47 0.39 5.47
 >40  2 (15%) 11 (85%) 0.22 0.05 0.94
Treatment delay
Time from diagnosis to treatment (per month) 10.04 7.18 1.02 1.00 1.04
Treatment decision
Physician 7 (15%) 39 (85%) Ref.
One option discussed 6 (16%) 31 (84%) 1.41 0.38 5.20
Physician recommended 4 (22%) 14 (78%) 1.41 0.29 6.86
Patient 27 (68%) 13 (33%) 17.51 5.37 57.08
Ambiguous 4 (25%) 12 (75%) 2.40 0.47 12.31

aOdds ratios adjusted for all variables in the logistic regression